A review of the evidence base for utilizing Child-Pugh criteria for guiding dosing of anticancer drugs in patients with cancer and liver impairment

As the liver is vital for the metabolism of many anticancer drugs, determining the correct starting doses in cancer patients with liver impairment is key to safe prescription and prevention of unnecessary adverse effects. Clinicians typically use liver function tests when evaluating patients; howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Palmieri, C., Macpherson, I.R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190488/
https://www.ncbi.nlm.nih.gov/pubmed/34098229
http://dx.doi.org/10.1016/j.esmoop.2021.100162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190488/
https://www.ncbi.nlm.nih.gov/pubmed/34098229
http://dx.doi.org/10.1016/j.esmoop.2021.100162

Ejemplares similares